Jonathan Gillis, CAAO and PAO at MapLight Therapeutics, Inc. (MPLT), sold 69,835 shares at $28.94 ($2.1M) on 2026-04-27, disclosed to the SEC on 2026-04-29.
Scheduled sale ($2.1M) by CAAO and PAO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.94 | 7,914 | $229K | 11.0% |
| 2 | $29.60 | 29,623 | $877K | 42.0% |
| 3 | $30.46 | 14,363 | $437K | 21.0% |
| 4 | $30.33 | 17,235 | $523K | 25.0% |
| 5 | $30.83 | 700 | $22K | 1.0% |
| Total | $29.89 avg | 69,835 |
| $2.1M |
| 100% |
| Filing → |